AFI Capital

AFI Capital Partners is a private growth equity and venture investment firm focused on early- and growth-stage companies in hyper-growth markets. The firm describes its strategy as investing primarily in ancillary businesses that enable or service emerging industries, rather than operating as a drug developer or healthcare product company. Publicly available sources associate the firm with investments across sectors including financial services, software, cannabis-related businesses, and selected biotechnology-related portfolio companies. AFI Capital Partners appears to be a private, active investment organization with a small team and U.S. presence in Washington and California. It is not itself a biotech, pharma, or healthcare operating company.